Drug recall · July 2, 2025
TESTO-200 recall
Why: Marketed Without an Approved NDA/ANDA
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
TESTO-200, Testosterone Cypionate Inj. USP, 2000mg/10ml (200mg/ml), One 10ml multidose vial per carton, For intramuscular injection only, Rx Only, ADVANCED PHARMACEUTICAL TECHNOLOGY, INC., 132 South Central Avenue, Elmsford, NY 10523. NDC 57377-200-01
- Lots / codes
Lot P-24-1; Exp. 02/28/2027
- Quantity
- 26 vials
- Company
- Advanced Pharmaceutical Technology, Inc., Elmsford, NY
- Distribution
- NY, NJ
- Initiated
- May 30, 2025 · Voluntary: Firm initiated
- Classified
- July 16, 2025
- Reported
- July 2, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Testosterone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.